Life Sciences

Life Sciences Law360 provides breaking legal news and analysis on the pharmaceutical and medical device industry. Coverage includes high-stakes litigation and policy developments that affect life sciences companies, as well as licensing deals, mergers, and other corporate transactions.



Sign up for a 7-day FREE trial today!



Latest News in Life Sciences

  • November 12, 2026

    Squires Grants Another 5 PTAB Petitions, Denies 2

    U.S. Patent and Trademark Office Director John Squires has instituted five new patent challenges, largely in the pharmaceutical industry, in one of his final mass orders.

  • November 12, 2026

    TikTok Backs School District In MDL Trial Witness Fight

    School district plaintiffs on Wednesday opposed a bid by YouTube, Snap and Meta to exclude late-disclosed witnesses from an upcoming bellwether trial in social media addiction multidistrict litigation, noting that defendant TikTok agreed the school district witnesses can be added if TikTok USDS Joint Venture's new CEO can testify as well.

  • November 12, 2026

    Anthropic Accused Of Infringing AI Attention Patents

    A Texas technology company sued Anthropic on Thursday claiming it was infringing a set of patents covering AI attention for training when working on its marquee chatbot model Claude.

  • November 10, 2026

    Costco Can't End Dog Food Heart Risk Suit Yet, Buyers Say

    Dog owners on Monday told a Washington federal judge that Costco's bid to dismiss their proposed class action alleging that its grain-free dog food contributes to canine heart disease ignores their factual allegations, saying that the company is cherry-picking from studies about the risk.

  • November 10, 2026

    Pharma Co. Investors Ink $4M Deal In FDA Hurdle Suit

    Verrica Pharmaceuticals and a group of investors have reached a $4 million deal to end claims that the company hid obstacles it faced in obtaining U.S. Food and Drug Administration approval for its lead product.

See more Life Sciences news

Life Sciences

Areas of Coverage

  • AGENCIES
  • U.S. Consumer Product Safety Commission
  • U.S. Food and Drug Administration
  • U.S. Patent and Trademark Office
  • U.S. International Trade Commission
  • POLICY & REGULATION
  • Affordable Care Act
  • Federal Food, Drug, and Cosmetic Act
  • Antitrust and consumer protection controls
  • Drug and medical device lobbying
  • State and international life sciences legislation and regulation
  • ENFORCEMENT
  • Drug and medical device recalls
  • Drug safety actions
  • Pay-for-delay investigations
  • Merger reviews
  • LITIGATION
  • Patent disputes, including
  • Abbreviated New Drug Application litigation
  • Section 301 cases
  • Product safety suits over drugs and medical devices, including off-label marketing and failure-to-warn claims
  • Consumer litigation and class actions
  • Fraud and compliance suits
  • Antitrust disputes
  • Labor and employment suits
  • Shareholder and corporate governance disputes
  • Bankruptcy proceedings
  • TRANSACTIONS
  • Mergers, acquisitions, and joint ventures
  • Share buybacks and stock splits
  • Private equity deals
  • Patent-licensing agreements
  • PROFILES
  • Personnel moves
  • Profiles of life sciences practice groups

Readership

  • Life sciences lawyers at top law firms
  • Corporate counsel and compliance officers at Fortune 1000 companies
  • Executives and attorneys in the drug, biotechnology, and medical device industries
  • Information experts at law firms, agencies, and companies
  • Policymakers at federal and state agencies
  • Judges and court staff across the U.S.
  • Professors, students, and library staff at every accredited law school in the U.S.
  • Attorney and law firm marketing professionals